Risk Factors and Outcomes of Post‐Transplant Erythrocytosis among Adult Kidney Transplant Recipients: A Systematic Review and Meta‐Analysis

2021 ◽  
Author(s):  
Poemlarp Mekraksakit ◽  
Boonphiphop Boonpheng ◽  
Natnicha Leelaviwat ◽  
Samapon Duangkham ◽  
Anasua Deb ◽  
...  
Keyword(s):  
Risk Factors ◽  
Systematic Review ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Post Transplant ◽  
Adult Kidney

scholarly journals Incidence and Impacts of Inflammatory Bowel Diseases among Kidney Transplant Recipients: A Meta-Analysis

2020 ◽  
Vol 8 (3) ◽  
pp. 39
Author(s):  
Panupong Hansrivijit ◽  
Max M. Puthenpura ◽  
Charat Thongprayoon ◽  
Himmat S. Brar ◽  
Tarun Bathini ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
De Novo ◽  
Meta Analysis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Post Transplant ◽  
Adult Kidney ◽  
Bowel Diseases ◽  
Inflammatory Bowel

Background: The incidence of inflammatory bowel diseases (IBD) and its significance in kidney transplant recipients is not well established. We conducted this systematic review and meta-analysis to assess the incidence of and complications from IBD in adult kidney transplant recipients. Methods: Eligible articles were searched through Ovid MEDLINE, EMBASE, and the Cochrane Library from inception through April 2020. The inclusion criteria were adult kidney transplant patients with reported IBD. Effect estimates from the individual studies were extracted and combined using the fixed-effects model when I2 ≤ 50% and random-effects model when I2 > 50%. Results: of 641 citations, a total of seven studies (n = 212) were included in the systematic review. The mean age was 46.2 +/− 6.9 years and up to 51.1% were male. The mean duration of follow-up was 57.8 +/− 16.8 months. The pooled incidence of recurrent IBD was 27.6% (95% CI, 17.7–40.5%; I2 0%) while the pooled incidence of de novo IBD was 18.8% (95% CI, 10.7–31.0%; I2 61.3%). The pooled incidence of post-transplant IBD was similar across subgroup analyses. Meta-regression analyses showed no association between the incidence of IBD and age, male sex, and follow-up duration. For post-transplant complications, the pooled incidence of post-transplant infection was 4.7% (95% CI, 0.5–33.3%; I2 73.7%). The pooled incidence of graft rejection and re-transplantation in IBD patients was 31.4% (95% CI, 14.1–56.1%; I2 76.9%) and 30.4% (95% CI, 22.6–39.5%; I2 0%). Conclusion: Recurrent and de novo IBD is common among kidney transplant recipients and may result in adverse outcomes.

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Kidney Transplant Recipients with Post-transplant Diabetes Mellitus (PTDM)- a Systematic Review and Meta-Analysis

2020 ◽  
Vol 16 (6) ◽  
pp. 580-585 ◽  
Author(s):  
Tarek Samy Abdelaziz ◽  
Ahmed Yamany Ali ◽  
Moataz Fatthy
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Mean Difference ◽  
Efficacy And Safety ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Dipeptidyl Peptidase 4 ◽  
Post Transplant

Background: Kidney transplant recipients may develop post-transplant diabetes mellitus (PTDM). Dipeptidyl peptidase 4(DPP-4) inhibitors are evolving agents in the management of patients with diabetes mellitus. Aims: To evaluate the efficacy and safety of DPP-4 inhibitors in the management of post-transplant diabetes mellitus (PTDM) in renal transplant recipients. Methods: We performed a systematic search of the electronic databases using keys words and Mesh terms. Data were extracted and reviewed using structured proforma. A comprehensive review of the eligible studies was performed independently by each of two reviewers; conflicts were resolved by the third reviewer. The primary efficacy endpoint was the difference in glycosylated hemoglobin (HbA1c) comparing any of the DPP-4 inhibitors to either placebo or other hypoglycaemic agent. The primary safety endpoints were the worsening of graft functions and change in Tacrolimus trough level. We performed the Random effect model using standardised mean difference. Results: We identified seven studies that were eligible for the systematic review; only one study compared Sitagliptin to insulin Glargine. One study involved head to head comparison of three DPP-4 inhibitors. The other five studies were pooled in the meta-analysis. DPP-4 inhibitors had a favourable glycemic effect as measured by HbA1c when compared to either placebo or oral anti-hyperglycemic medications (standardised mean difference in HbA1c = -0.993, 95% CI= -1.303 to -0.683, P=0.001). DPP-4 inhibitors use did not result in significant change in eGFR ((standardised mean difference = 0.147, 95% CI= -0.139 - 0.433, p=0.312).) nor Tacrolimus level (standardised Mean Difference= 0.152, 95% CI= -0.172 to 0.477, P=0.354). Conclusion: Current evidence supports the short term efficacy and safety of DDP-4 inhibitor agents in the management of post transplantation diabetes mellitus (PTDM) in kidney transplant recipients. However, more RCTs are required to investigate the long-term safety and efficacy of these agents in kidney transplant recipients.

Cognition in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.

2014 ◽  
Vol 98 ◽  
pp. 845-846 ◽  
Author(s):  
P. Masson ◽  
S. Wu ◽  
F. Duthie ◽  
S. Palmer ◽  
G. Strippoli ◽  
...  
Keyword(s):  
Systematic Review ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis

2016 ◽  
Vol 30 (9) ◽  
pp. 1090-1096 ◽  
Author(s):  
Stephanie M. Toth-Manikowski ◽  
Jean M. Francis ◽  
Amitabh Gautam ◽  
Craig E. Gordon
Keyword(s):  
Systematic Review ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Bisphosphonate Therapy ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

Decline in prevalence and risk of helicobacter pylori in kidney transplant recipients: A systematic review and meta-analysis

2017 ◽  
Vol 10 (3) ◽  
pp. 171-176 ◽  
Author(s):  
Wisit Cheungpasitporn ◽  
Charat Thongprayoon ◽  
Karn Wijarnpreecha ◽  
Donald G. Mitema ◽  
Michael A. Mao ◽  
...  
Keyword(s):  
Systematic Review ◽  
Helicobacter Pylori ◽  
Kidney Transplant ◽  
Meta Analysis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document